Morgan Stanley cuts Bath & Body Works target to $41, keeps Overweight

Morgan Stanley reduced its BBWI price target to $41 from $43, maintaining an Overweight rating, after Q1 results showed sales exceeding expectations but Q2 guidance falling short. Despite reiterating full-year guidance, uncertainty persists due to a lack of clarity and less tariff protection than anticipated. Piper Sandler also lowered its price target to $37 from $39, while maintaining an Overweight rating, even as Q1 EPS of $0.49 beat estimates, though revenue slightly missed at $1.4 billion versus the $1.42 billion forecast.

Analysis

Morgan Stanley and Piper Sandler have adjusted their price targets downwards for Bath & Body Works Inc. (BBWI) to $41.00 (from $43.00) and $37.00 (from $39.00) respectively, although both firms maintain an Overweight rating. This recalibration follows BBWI's first-quarter performance, where earnings per share reached $0.49, surpassing the $0.42 analyst consensus, yet revenue of $1.4 billion slightly missed the $1.42 billion forecast. While Q1 sales reportedly exceeded Morgan Stanley's expectations, they were accompanied by undisclosed negative elements. A key concern stems from the company's second-quarter guidance, which fell short of analyst projections, compounding uncertainty. Furthermore, although BBWI reiterated its full-year guidance for 1-3% net sales growth and an EPS range of $3.25 to $3.60, a perceived lack of clarity around this forecast and less tariff protection than anticipated introduce additional risk factors related to international trade fluctuations. Despite these challenges, BBWI demonstrates fundamental strengths with a gross profit margin of 44.26% and a 2.8% dividend yield. The company is actively pursuing growth through strategic initiatives such as product innovation, including a Disney Princess collection, digital platform enhancements, and exploration of international expansion, underscored by management's focus on a consumer-centric approach.

Key Decisions for Investors

• Investors should acknowledge the mixed operational signals from BBWI, including a Q1 EPS beat against a slight revenue miss and cautious Q2 guidance, alongside reduced analyst price targets that temper maintained Overweight ratings, warranting a cautious investment posture.
• Monitor upcoming quarterly results closely for tangible progress on strategic initiatives like product innovation and international expansion, clearer articulation of the full-year outlook, and effective management of tariff-related headwinds.
• While BBWI's 2.8% dividend yield and 44.26% gross profit margin offer some financial stability, these should be weighed against the current uncertainties in guidance and the broader specialty retail sector before considering new or increased positions.